Evaluation of Ocular Comfort With ISTA Tears vs Systane

To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Disease Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

ISTA Pharmaceuticals, Inc.

Irvine, California, 92618, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

OSDI >12

Exclusion criteria

Presence of any active ocular disease other than dry eye

Treatment and study plan

ISTA Tears

Drug

sterile ophthalmic solution

Systane

Drug

Sterile ophthalmic solution

Primary outcomes

Percentage of Participants With Preference for One of the Treatments

Time frame: 30 days

There were 35 participants who applied ISTA Tears to the right eye and Systane to the left eye (70 eyes total). Participants were asked to indicate which treatment they preferred, or if they preferred neither.

Sponsors and collaborators

Lead sponsor

Bausch & Lomb Incorporated

Industry

Registry information

Important dates

Study start: 2012
Primary completion: 2012
Study completion: 2013
First posted: Jul 26, 2012
Registry last updated: Oct 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed